Medicinal cannabis given to 20,000 Brit patients in first major trial

Medicinal cannabis given to 20,000 Brit patients in first major trial

Medicinal cannabis will be given to 20,000 British patients in first major trial of drug’s imp...
read more
Treating the TOTAL patient: clinical trial reduces relapse

Treating the TOTAL patient: clinical trial reduces relapse

Despite modern therapies, 10% of patients with acu...
read more
Chlamydia vaccine moves a step closer after a trial proves it is safe

Chlamydia vaccine moves a step closer after a trial proves it is safe

Chlamydia vaccine moves one step closer after the ...
read more
Early trial shows promise for MDMA as an alcoholism treatment

Early trial shows promise for MDMA as an alcoholism treatment

Scientists use ECSTASY to ‘cure alcoholics&#...
read more
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS

MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS

LA JOLLA, Calif., April 15, 2019 (GLOBE NEWSWIRE) ...
read more
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas

Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas

WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) &#...
read more
New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

PARIS, Jan. 9, 2019 /PRNewswire/ — The New E...
read more